STREPTOKINASE — all Canadian products
9 DINs
0 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is STREPTOKINASE, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02126141 | KABIKINASE - PWS 1500000UNITS/VIAL | PHARMACIA & UPJOHN INC | Powder For Solution | Intravenous; Intracoronary | STREPTOKINASE 1500000 UNIT | Cancelled Post Market | |
| 02126125 | KABIKINASE - PWS 250000 UNIT/VIAL | PHARMACIA & UPJOHN INC | Powder For Solution | Intracoronary; Intravenous | STREPTOKINASE 250000 UNIT | Cancelled Post Market | |
| 02126133 | KABIKINASE - PWS 750000UNITS/VIAL | PHARMACIA & UPJOHN INC | Powder For Solution | Intravenous; Intracoronary | STREPTOKINASE 750000 UNIT | Cancelled Post Market | |
| 02019000 | STREPTASE | CSL BEHRING CANADA INC | Powder For Solution | Intracoronary; Intravenous | STREPTOKINASE 750000 UNIT | Cancelled Post Market | |
| 02018993 | STREPTASE | CSL BEHRING CANADA INC | Powder For Solution | Intravenous; Intracoronary | STREPTOKINASE 250000 UNIT | Cancelled Post Market | |
| 02019019 | STREPTASE | CSL BEHRING CANADA INC | Powder For Solution | Intravenous; Intracoronary | STREPTOKINASE 1500000 UNIT | Cancelled Post Market | |
| 00881686 | STREPTASE INJ 1500000 UNIT/VIAL | HOECHST CANADA INC. | Powder For Solution | Intravenous | STREPTOKINASE 1500000 UNIT | Cancelled Post Market | |
| 00527157 | STREPTASE INJ 250000UNIT/VIAL | HOECHST CANADA INC. | Powder For Solution | Intravenous | STREPTOKINASE 250000 UNIT | Cancelled Post Market | |
| 00527149 | STREPTASE INJ 750000UNIT/VIAL | HOECHST CANADA INC. | Powder For Solution | Intravenous | STREPTOKINASE 750000 UNIT | Cancelled Post Market |
Browse other molecules: